Search results
AbbVie names Roxanne Austin as new lead independent director By Investing.com
Investing.com· 9 hours agoAustin will be taking over from Glenn F. Tilton, who will continue his tenure on the board as an...
As AbbVie Drug Gets FDA Nod, Traders Can Look Up to These Targets
TheStreet.com· 14 hours agoAbbVie (ABBV) on Wednesday won Food and Drug Administration approval for a new use for its drug...
AbbVie Inc. (NYSE:ABBV) Shares Sold by Mather Group LLC.
ETF DAILY NEWS· 12 hours agoMather Group LLC. trimmed its stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 31.1% in the 1st quarter, according to its most recent 13F filing with the Securities ...
Rowlandmiller & PARTNERS.ADV Sells 250 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 12 hours agoRowlandmiller & PARTNERS.ADV decreased its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 0.5% during the first quarter, HoldingsChannel reports. The institutional ...
AbbVie stock price forecast: $200 on the cards? | Invezz
Invezz· 12 hours agoOn June 20, 2024, AbbVie Inc. (NYSE:ABBV) announced that it has received FDA approval for expanding the use of its interleukin-23 (IL-23) inhibitor, Skyrizi, to treat adults ...
AbbVie Inc. (NYSE:ABBV) Holdings Cut by Carolina Wealth Advisors LLC
ETF DAILY NEWS· 15 hours agoCarolina Wealth Advisors LLC decreased its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 5.2% during the 1st quarter, according to its most recent filing ...
Bath Savings Trust Co Acquires 196 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 15 hours agoBath Savings Trust Co increased its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 1.0% during the 1st quarter, according to its most recent Form 13F filing ...
GAMMA Investing LLC Has $3.53 Million Stock Position in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 15 hours agoGAMMA Investing LLC boosted its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 18.9% during the first quarter, according to the company in its most recent filing with the ...
Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years - AbbVie (NYSE:ABBV)
Benzinga· 6 hours agoAbbVie ABBV has outperformed the market over the past 10 years by 1.28% on an annualized basis producing an average annual return of 12.11%. Currently, AbbVie< ...
Why AbbVie (ABBV) is a Great Dividend Stock Right Now
Zacks via Yahoo Finance· 1 day agoDividends are one of the best benefits to being a shareholder, but finding a great dividend stock is...